UBS Group’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-184,891
Closed -$324K 10751
2025
Q1
$324K Buy
184,891
+94,744
+105% +$125K ﹤0.01% 6186
2024
Q4
$142K Buy
90,147
+60,271
+202% +$92.6K ﹤0.01% 6662
2024
Q3
$46.9K Buy
29,876
+10,659
+55% +$17.6K ﹤0.01% 6862
2024
Q2
$34.3K Buy
19,217
+18,915
+6,263% +$43.9K ﹤0.01% 6976
2024
Q1
$870 Sell
302
-42
-12% -$68 ﹤0.01% 8327
2023
Q4
$440 Sell
344
-64
-16% -$85 ﹤0.01% 8656
2023
Q3
$558 Sell
408
-3,204
-89% -$4.64K ﹤0.01% 8406
2023
Q2
$5.31K Buy
3,612
+1,874
+108% +$2.5K ﹤0.01% 7456
2023
Q1
$1.47K Sell
1,738
-3,924
-69% -$5.19K ﹤0.01% 8728
2022
Q4
$7.76K Sell
5,662
-4,514
-44% -$7.1K ﹤0.01% 8863
2022
Q3
$17K Buy
10,176
+1,924
+23% +$3.46K ﹤0.01% 7614
2022
Q2
$17K Buy
8,252
+2,081
+34% +$5.05K ﹤0.01% 7111
2022
Q1
$18K Buy
6,171
+3,776
+158% +$9.82K ﹤0.01% 7582
2021
Q4
$8K Buy
2,395
+408
+21% +$1.81K ﹤0.01% 9053
2021
Q3
$14K Buy
+1,987
New +$14.6K ﹤0.01% 7593
2021
Q1
Sell
-280
Closed -$4K 9390
2020
Q4
$4K Buy
+280
New +$2.06K ﹤0.01% 7927
2020
Q3
Sell
-90
Closed -$1K 8344
2020
Q2
$1K Buy
+90
New +$589 ﹤0.01% 7794
2020
Q1
Sell
-819
Closed -$7K 8326
2019
Q4
$7K Sell
819
-859
-51% -$5.97K ﹤0.01% 7458
2019
Q3
$12K Buy
+1,678
New +$13.7K ﹤0.01% 7058
2019
Q2
Sell
-197
Closed -$2K 8108
2019
Q1
$2K Buy
197
+103
+110% +$1.12K ﹤0.01% 7464
2018
Q4
$1K Sell
94
-40
-30% -$662 ﹤0.01% 7916
2018
Q3
$3K Buy
134
+9
+7% +$297 ﹤0.01% 7661
2018
Q2
$10K Buy
+125
New +$10.3K ﹤0.01% 7143
2018
Q1
Sell
-153
Closed -$19K 8104
2017
Q4
$19K Buy
153
+150
+5,000% +$19K ﹤0.01% 6599
2017
Q3
$0 Sell
3
-258
-99% -$32.4K ﹤0.01% 7941
2017
Q2
$31K Sell
261
-49
-16% -$8.18K ﹤0.01% 5997
2017
Q1
$61K Buy
310
+20
+7% +$3.81K ﹤0.01% 5374
2016
Q4
$78K Buy
290
+72
+33% +$23.4K ﹤0.01% 5469
2016
Q3
$86K Sell
218
-51
-19% -$21K ﹤0.01% 5083
2016
Q2
$92K Buy
269
+11
+4% +$7.88K ﹤0.01% 5086
2016
Q1
$214K Buy
258
+136
+111% +$108K ﹤0.01% 4448
2015
Q4
$127K Buy
122
+41
+51% +$41.1K ﹤0.01% 5033
2015
Q3
$64K Buy
81
+14
+21% +$14.4K ﹤0.01% 5603
2015
Q2
$88K Buy
67
+12
+22% +$19.4K ﹤0.01% 5511
2015
Q1
$112K Buy
55
+47
+588% +$102K ﹤0.01% 5325
2014
Q4
$16K Buy
+8
New +$14.2K ﹤0.01% 7961

Other funds holding RGLS